Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural Daylight to Improve 24h Metabolism and Glucose Control in Type 2 Diabetes

NCT05263232 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT05263232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05263232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural Daylight to Improve 24h Metabolism and Glucose Control in Type 2 Diabetes
Lead sponsor
Maastricht University
Phase
Not applicable
Overall status
Completed
Start date
March 16, 2022
Completion date
April 18, 2023
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circadian dysregulation, diabetes mellitus, type 2